Q3 FY26 Earnings

LargestFastest profit growthFastest sales growthBiggest beatsBiggest misses

Sector All sectorsAerospace & DefenseAutomobilesAviationBanksBeveragesCablesCapital GoodsCapital MarketsCastings, Forgings & FastnersChemicalsCommercial ServicesCommoditiesConstructionConsumer DiscretionaryConsumer DurablesConsumer GoodsConsumer ServicesDiamond, Gems and JewelleryDiversifiedEducationEnergyEngineering ServicesFast Moving Consumer GoodsFinancial ServicesFMCGFood ProductsForest MaterialsHealthcareHealthcare ServicesIndustrial ProductsIndustrialsInformation TechnologyInsuranceLeisure ServicesLogistics & CargoMediaMetals & MiningOil & GasPackagingPetroleum ProductsPowerPrinting & StationeryRealtyRetailServicesSteelTelecomTelecommunicationTextilesTradingTransportTransport ServicesUtilities Result Any resultBeatMissedIn lineNo estimate Clear filters 201–235 of 235

Company		Revenue (₹ Cr)			Profit (₹ Cr)		Per share		8Q profit
Symbol	Sector	Reported ↓	YoY	QoQ	Reported	YoY	EPS	vs consensus	Trend
BERYLDRUGSLTD Beryl Drugs Ltd	Healthcare	4	down-28.7%	down-25.4%	-0	down-440.0%	-0.34	No estimate
DECIPHERLABSLTD Decipher Labs Ltd	Healthcare	3	down-44.7%	down-25.5%	-1	n/a	-0.53	No estimate
ISHITADRUGSINDUSLTD Ishita Drugs & Industries Ltd	Healthcare	3	down-24.0%	up+2.3%	0	down-33.3%	0.54	No estimate
SUVEN Suven Life Sciences Ltd	Healthcare	3	up+50.0%	up+200.0%	-102	n/a	-4.48	No estimate
SH — Sangam Health Care Products Ltd	Healthcare	3	down-5.2%	down-10.5%	0	up+81.8%	0.13	No estimate
ZENITHHEALTHCARELTD Zenith Health Care Ltd	Healthcare	2	up+7.4%	up+9.3%	0	n/a	0.04	No estimate
VISTAPHARMACEUTICALSLTD Vista Pharmaceuticals Ltd	Healthcare	2	down-5.5%	up+65.8%	-2	n/a	-0.38	No estimate
LASA Lasa Supergenerics Ltd	Healthcare	2	down-93.3%	down-28.1%	-3	down-146.4%	-0.51	No estimate
GI GUJINJECLTD Gujarat Inject (Kerala) Ltd	Healthcare	2	down-48.3%	up+3.2%	0	down-81.0%	0.00	No estimate
ACHYUTHEALTHCARELTD Achyut Healthcare Ltd	Healthcare	2	n/a	down-38.4%	0	down-100.0%	0.00	No estimate
VD VENMAXDRUGSPHARMACEUTICALSLTD Venmax Drugs & Pharmaceuticals Ltd	Healthcare	2	up+675.0%	up+17.4%	0	n/a	0.04	No estimate
COLINZLABORATORIESLTD Colinz Laboratories Ltd	Healthcare	1	down-2.7%	up+2.9%	0	up+60.0%	0.32	No estimate
DESHRAKSHAKAUSHDHALAYALTD Desh Rakshak Aushdhalaya Ltd	Healthcare	1	down-25.5%	up+47.4%	0	down-25.0%	0.16	No estimate
BIOFILCHEM Biofil Chemicals & Pharmaceuticals Ltd	Healthcare	1	down-93.9%	down-93.6%	0	down-50.0%	0.05	No estimate
MEDICAPQ Medi Caps Ltd	Healthcare	1	up+196.2%	down-23.0%	0	n/a	0.23	No estimate
SHREEGANESHBIOTECHINDIALTD Shree Ganesh Biotech India Ltd	Healthcare	1	down-95.1%	down-9.1%	0	down-58.4%	0.01	No estimate
RL REKVINALABORATORIESLTD Rekvina Labs Ltd	Healthcare	0	n/a	up+75.0%	-0	n/a	-0.10	No estimate
DM — Dolphin Medical Services Ltd	Healthcare	0	down-12.5%	up+16.7%	0	up+100.0%	0.01	No estimate
SC SHYAMAINFOLTD Shyama Computronics and Services Ltd	Healthcare	0	up+16.7%	0.0%	0	up+100.0%	0.04	No estimate
GENOMICVALLEYBIOTECHLTD Genomic Valley Biotech Ltd	Healthcare	0	down-77.3%	down-44.4%	0	down-93.8%	0.03	No estimate
ORTINGLOBE Ortin Global Ltd	Healthcare	0	down-66.7%	0.0%	-0	n/a	-0.06	No estimate
AMBALALSA Ambalal Sarabhai Enterprises Ltd	Healthcare	0	down-100.0%	down-100.0%	2	down-78.2%	0.24	No estimate
TRANSCHEMLTD Transchem Ltd	Healthcare	0	down-100.0%	n/a	1	down-61.9%	0.43	No estimate
SM CHEMOPHARMALABORATORIESLTD Starsource Multitrade Ltd	Healthcare	0	n/a	down-100.0%	-0	n/a	-0.60	No estimate
TRIOCHEMPRODUCTSLTD Triochem Products Ltd	Healthcare	0	n/a	n/a	-0	down-244.4%	-5.31	No estimate
CG GENESISIBRCINDIALTD CCME Global Ltd	Healthcare	0	n/a	n/a	-0	n/a	-0.02	No estimate
BACILPHARMALTD Bacil Pharma Ltd	Healthcare	0	n/a	n/a	0	n/a	0.03	No estimate
KAMRONLABORATORIESLTD Adline Chem Lab Ltd	Healthcare	0	n/a	n/a	-0	n/a	-0.10	No estimate
WELCUREDRUGSPHARMACEUTICALSLTD Welcure Drugs & Pharmaceuticals Ltd	Healthcare	0	down-100.0%	down-100.0%	1	n/a	0.01	No estimate
CG RAYMEDLABSLTD Cresanto Global Limited	Healthcare	0	n/a	down-100.0%	-0	n/a	-0.21	No estimate
MP — MPS Pharmaa Ltd	Healthcare	0	n/a	n/a	-0	n/a	-0.12	No estimate
NECLIFE Nectar Lifescience Ltd	Healthcare	0	n/a	down-100.0%	14	up+75.0%	0.64	No estimate
TAKE Take Ltd	Healthcare	0	n/a	n/a	1	down-97.7%	0.08	No estimate
TL — Transchem Ltd	Healthcare	0	down-100.0%	n/a	1	down-61.9%	0.43	No estimate
HP — Harleystreet Pharmaceuticals Ltd(merged)	Healthcare	—	n/a	n/a	185	up+22.5%	5.74	No estimate

About Q3 FY26 earnings data

When are Q3 FY26 results announced?

Q3 FY26 covers the Oct–Dec 2025 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.

Why do some Q3 FY26 growth figures show "n/a" instead of a percentage?

Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.

Does the beat/miss verdict cover every company?

No, and the denominator matters. An analyst consensus existed for 333 of the 5,039 companies that reported Q3 FY26 — 6.6%. Beat, missed and in-line describe only those. Every other company is marked "no estimate" rather than being counted as in line, because nobody forecast it. Revenue and profit growth, by contrast, cover every company in the table.

What counts as an in-line result rather than a beat or a miss?

Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.

Are the figures consolidated or standalone?

Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.

What does the 8-quarter trend line show?

Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.

How do I find only the companies that beat estimates in Q3 FY26?

Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.